NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
Back to search
Official data from USPTO
CT RS CELL THERAPIES RESEARCH & SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/04/2023
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
02/18/2022
Registration date
04/04/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Boulogne-Billancourt, FR
Examiner
ENGEL, MICHAEL
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "CTRS" in blue with a red circle between the letters "CT" and "RS" and with a blue line below the letters and the stylized words "CELL THERAPIES RESEARCH & SERVICES" in black below the blue line. The color white represents background and/or transparent areas and is not part of the mark.
Holders and representatives
Holders
L. C. (pessoa física)
Representatives
Pina Campagna CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietetic food and substances adapted for medical use; Biological preparations for the prevention and treatment of biliary insufficiencyinflammatory conditions and diseasehematological conditions and cancer; Pharmaceuticals for the treatment of biliary insufficiencyinflammatory conditions and diseasehematological conditions and cancer; Chemical preparations for medical and pharmaceutical purposesfor the prevention and the treatment of biliary insufficiencyinflammatory conditions and diseasehematological conditions and cancer; Bacteriological preparations for medical purposes; Stem cells for medical purposes; Diagnostic preparations for medical purposes
Class 42
Medical laboratory services; Research and development of new products for others in the medicalpharmaceutical and biotechnology field; Research and development in the medicalpharmaceutical and biotechnology field; Medical and scientific researchconducting clinical trials for others; Providing of information relating to medical and scientific research; Consultancy services in the field of biotechnology
Class 44
Medical information; Medical analysis services relating to the treatment of patients; Providing information regarding pharmaceutical products; Medical diagnostic testingmonitoringreporting services; Consultancy services in the field of pharmaceutical products; Medical services; Health counselling
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/10/2022
ALIE
ASSIGNED TO LIE
12/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/09/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/09/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2022
GNRT
NON-FINAL ACTION E-MAILED
12/04/2022
CNRT
NON-FINAL ACTION WRITTEN
12/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2022
GNRT
NON-FINAL ACTION E-MAILED
07/08/2022
CNRT
NON-FINAL ACTION WRITTEN
07/08/2022
DOCK
ASSIGNED TO EXAMINER
06/29/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/24/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2022
NWAP
NEW APPLICATION ENTERED
02/22/2022
Continuous trademark protection
Get notified about every new filing that threatens CT RS CELL THERAPIES RESEARCH & SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.